X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with J.B.Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs J.B.CHEMICALS - Comparison Results

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA J.B.CHEMICALS ELDER PHARMA/
J.B.CHEMICALS
 
P/E (TTM) x -0.2 14.0 - View Chart
P/BV x 0.1 2.2 4.6% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 ELDER PHARMA   J.B.CHEMICALS
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
J.B.CHEMICALS
Mar-16
ELDER PHARMA/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs380318 119.5%   
Low Rs188200 94.2%   
Sales per share (Unadj.) Rs491.2148.0 331.9%  
Earnings per share (Unadj.) Rs-3.219.1 -16.7%  
Cash flow per share (Unadj.) Rs14.423.9 60.2%  
Dividends per share (Unadj.) Rs00.50 0.0%  
Dividend yield (eoy) %00.2 0.0%  
Book value per share (Unadj.) Rs376.5128.9 292.0%  
Shares outstanding (eoy) m20.5484.82 24.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.61.7 33.1%   
Avg P/E ratio x-89.313.6 -658.2%  
P/CF ratio (eoy) x19.710.8 182.4%  
Price / Book Value ratio x0.82.0 37.6%  
Dividend payout %02.6 0.0%   
Avg Mkt Cap Rs m5,83321,951 26.6%   
No. of employees `000NA2.7 0.0%   
Total wages/salary Rs m2,1791,841 118.3%   
Avg. sales/employee Rs ThNM4,590.9-  
Avg. wages/employee Rs ThNM673.4-  
Avg. net profit/employee Rs ThNM592.1-  
INCOME DATA
Net Sales Rs m10,08912,551 80.4%  
Other income Rs m257542 47.4%   
Total revenues Rs m10,34613,093 79.0%   
Gross profit Rs m-7922,055 -38.5%  
Depreciation Rs m361412 87.6%   
Interest Rs m2,75696 2,880.1%   
Profit before tax Rs m-3,6532,088 -174.9%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m125469 26.7%   
Profit after tax Rs m-651,619 -4.0%  
Gross profit margin %-7.816.4 -47.9%  
Effective tax rate %-3.422.5 -15.3%   
Net profit margin %-0.612.9 -5.0%  
BALANCE SHEET DATA
Current assets Rs m9,2407,778 118.8%   
Current liabilities Rs m9,9984,358 229.4%   
Net working cap to sales %-7.527.2 -27.6%  
Current ratio x0.91.8 51.8%  
Inventory Days Days4655 84.7%  
Debtors Days Days6080 74.9%  
Net fixed assets Rs m10,1245,713 177.2%   
Share capital Rs m206170 121.3%   
"Free" reserves Rs m5,58210,547 52.9%   
Net worth Rs m7,73410,937 70.7%   
Long term debt Rs m4,8890-   
Total assets Rs m22,88215,574 146.9%  
Interest coverage x-0.322.8 -1.4%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.40.8 54.7%   
Return on assets %11.811.0 106.8%  
Return on equity %-0.814.8 -5.7%  
Return on capital %22.320.0 111.8%  
Exports to sales %3.048.7 6.2%   
Imports to sales %0.47.1 6.0%   
Exports (fob) Rs m3076,115 5.0%   
Imports (cif) Rs m43889 4.8%   
Fx inflow Rs m3076,169 5.0%   
Fx outflow Rs m1251,285 9.8%   
Net fx Rs m1814,884 3.7%   
CASH FLOW
From Operations Rs m11,7541,397 841.6%  
From Investments Rs m-561-320 175.0%  
From Financial Activity Rs m-6,762-1,196 565.5%  
Net Cashflow Rs m4,432-102 -4,332.1%  

Share Holding

Indian Promoters % 39.6 55.4 71.5%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 7.5 3.4 221.2%  
FIIs % 16.8 3.9 430.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 37.0 97.6%  
Shareholders   16,479 30,437 54.1%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   FULFORD INDIA  VENUS REMEDIES  STERLING BIOTECH  CADILA HEALTHCARE  AUROBINDO PHARMA  

Compare ELDER PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Red; Auto Stocks Witness Selling(01:30 pm)

After opening the day flat, share markets in India continued to witness selling pressure and are currently trading in red. Sectoral indices are trading on a mixed note with stocks in the metals sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - MERCK LTD COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS